Pelage Pharmaceuticals

Pelage Pharmaceuticals is a company focused on developing a novel, non-invasive treatment for hair loss. Their platform utilizes a small molecule drug that directly targets the hair follicle stem cells, stimulating hair growth by reactivating dormant stem cells. This approach is designed to be effective for all genders, skin types, and hair types, unlike existing treatments that often have limited efficacy and are not suitable for all patients.

Pelage's research is grounded in groundbreaking discoveries by their co-founders, who have identified a unique metabolic switch within hair follicle stem cells. Their drug works by targeting this switch, restoring the follicle's regenerative capacity and triggering new hair growth. Currently in Phase 2a clinical trials for androgenetic alopecia, Pelage is actively seeking to revolutionize hair loss treatment with their innovative and clinically tested solution.

Pelage Pharmaceuticals is a company dedicated to developing a novel, non-invasive treatment for hair loss. Their mission is to provide a clinically-tested, scientifically grounded solution for all genders, skin types, and hair types, regardless of the cause of hair loss. By targeting the metabolic switch in hair follicle stem cells, Pelage aims to reactivate dormant stem cells and stimulate robust hair growth, offering a new hope for those struggling with hair loss.

Pelage Pharmaceuticals promotes a culture of innovation and collaboration, fueled by a commitment to scientific rigor and a shared passion for developing groundbreaking treatments for hair loss. The company emphasizes inclusivity, actively recruiting women and men for clinical trials, and aiming to develop solutions that benefit all genders, skin types, and hair types. This focus on cutting-edge research, diversity, and patient-centric solutions creates a dynamic and driven work environment.

Pelage Pharmaceuticals is committed to fostering a diverse, equitable, and inclusive workplace. They highlight their commitment to serving all genders, skin types, and hair types with their hair loss treatment. This is evident in their clinical trials which include both men and women with androgenetic alopecia. Pelage also boasts a diverse leadership team, highlighting their commitment to representation and inclusivity.